MedPath

Therapeutic effect of stem cell secretions on Crohn's disease

Phase 2
Recruiting
Conditions
Patients with peri-anal fistula in Crohn’s disease.
Crohn's disease of both small and large intestine with fistula
K50.813
Registration Number
IRCT20200809048342N2
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Males or females between 18-75 years old with a clinically confirmed diagnosis of Crohn’s disease
Medical therapy resistant perianal fistula
Mild to moderate Crohn’s disease activity index

Exclusion Criteria

Any reasons which reported as side effect of interventions
If participants would like to leave the trials for any reasons
Active infectious disease
Pregnant patient
Liver or kidney insufficiency
Underlying malignancy
Uncontrolled diabetes
History of chemoradiotherapy
Patients with immunodeficiency
Severe Crohn’s disease activity index

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath